May 20, 2024
Electric Linear Cylinders Market
Ict

The Growing Demand For Automation Is Driving The Electric Linear Cylinders Market

Electric linear cylinders provide linear motion and positioning with electronic controls. Used for industrial automation and assembly applications, these cylinders offer precise control, repeatability and energy efficiency compared to pneumatic cylinders. Key features include integrated position or force sensors to provide feedback, onboard electronics and software for programmable operation. The global growth in industrial automation has increased demand for electric linear actuators to power automated machinery and robotics. Electric cylinders enable the development of automated assembly lines and facilitate production processes across manufacturing industries. Their digital controls allow for networked communication with supervisory control systems to achieve coordinated multi-axis motion.

The global Electric Linear Cylinders Market is estimated to be valued at US$ 799.18 Mn  in 2023 and is expected to exhibit a CAGR of 9.6%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends

The adoption of Industry 4.0 technologies is driving demand for smart electric cylinders. Integrating electric linear cylinders with internet of things (IoT) connectivity and sensors enables remote monitoring and predictive maintenance. Data from force, position and other sensors can be analyzed to digitally track system performance, detect anomalies and schedule servicing. This increases overall equipment effectiveness. Another trend is the development of compact electric linear actuators optimized for collaborative robotics and integration into small spaces. Miniaturized designs with integrated drivers and controls facilitate new applications in electronics assembly, medical devices as well as consumer product manufacturing. Overall, advances in digitalization and connectivity are transforming electric cylinders into intelligent actuators central to smart automated production environments.

Porter’s Analysis

Threat of new entrants: Low implementation and production costs make it relatively easy for new players to enter the electric linear cylinders market. However, established players have strong brand recognition and economies of scale which create barriers.

Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitutes. However, customized requirements give advantage to larger players.

Bargaining power of suppliers: Leading manufacturers source raw materials like screws, nuts, and bolts from few specialized suppliers giving them bargaining power.

Threat of new substitutes: Substitutes like pneumatic cylinders offer comparable functionality at lower costs. however, electric cylinders are gaining traction due to various advantages.

Competitive rivalry: The market has the presence of numerous global and regional players leading to high competition. Players differentiate through product innovation, quality, and service.

Key Takeaways

The global Electric Linear Cylinders Market Share is expected to witness high growth at a CAGR of 9.6%  during the forecast period. The global Electric Linear Cylinders Market is estimated to be valued at US$ 799.18 Mn in 2023 and is expected to exhibit a CAGR of 9.6%  over the forecast period 2023 to 2030.

North America captured over 35% of global market share in 2023 owing to strong manufacturing sector and early technology adoption. Asia Pacific region is expected to grow at fastest pace due to increasing industrialization and the presence of emerging economies like China and India. China dominates the regional market with over 15% production globally.

Key players
Key players operating in the Electric Linear Cylinders market are Amgen Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol-Myers Squibb Company, NanoString, QIAGEN, Affimed GmbH, GSK plc., Merck KgaA, and Teva Pharmaceutical Industries Ltd.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it